{
  "id": "R46741",
  "type": "CRS Report",
  "typeId": "R",
  "number": "R46741",
  "active": true,
  "source": "CRSReports.Congress.gov",
  "versions": [
    {
      "source_dir": "crsreports.congress.gov",
      "title": "Drug Pricing and Intellectual Property: The Legislative Landscape for the 117th Congress",
      "retrieved": "2021-04-26T04:03:17.760958",
      "id": "R46741_1_2021-03-31",
      "formats": [
        {
          "filename": "files/2021-03-31_R46741_a05e1515155003b928fa78aca7feabe227f85f60.pdf",
          "format": "PDF",
          "url": "https://crsreports.congress.gov/product/pdf/R/R46741/1",
          "sha1": "a05e1515155003b928fa78aca7feabe227f85f60"
        },
        {
          "format": "HTML",
          "filename": "files/2021-03-31_R46741_a05e1515155003b928fa78aca7feabe227f85f60.html"
        }
      ],
      "date": "2021-03-31",
      "summary": null,
      "source": "CRSReports.Congress.gov",
      "typeId": "R",
      "active": true,
      "sourceLink": "https://crsreports.congress.gov/product/details?prodcode=R46741",
      "type": "CRS Report"
    }
  ],
  "topics": []
}